Pharmacist Administration of Long-Acting Injectable Antipsychotics

Policy Research

NEW! Pharmacist Authority to Administer Long-Acting Injectable Antipsychotic Medications

 

Policy Recommendations

The National Alliance of State Pharmacy Associations (NASPA) and the College of Psychiatric and Neurologic Pharmacists (CPNP) convened a stakeholder group in 2016/2017 to develop policy recommendations related to pharmacist administration of medications. These recommendations address the role of pharmacists in the administration of medications (beyond vaccines). The group took a deeper dive look specifically at the administration of long-acting antipsychotic medications (LAIs) because of the opportunity to resolve some access issues that are specific to these important medications.

Below is the report from that stakeholder group along with other resources that relate to pharmacist administration of medications.
Read the Report

American Pharmacists Association (APhA) Report 

The American Pharmacists Association (APhA) has also published work related to medication administration. This report details discussions from the APhA Stakeholder Conference and includes practice-based issues relating to pharmacist administration of medications.
Read the Report